INS and obstructive sleep apnea syndrome: Previous small-scale clinical studies have found that patients with obstructive sleep apnea syndrome (OSAS) who receive continuous positive airway pressure (CPAP) treatment can improve insulin resistance, oxidative stress, and inflammatory responses, thereby reducing CVD risk (43).